• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety.低氧诱导因子脯氨酰羟化酶抑制剂：疗效已获证实，但安全性尚不确定。
Am J Nephrol. 2021;52(10-11):894-898. doi: 10.1159/000518073. Epub 2021 Sep 16.
2
Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety".对《缺氧诱导因子脯氨酰羟化酶抑制剂：疗效确切但安全性存疑》的回应信
Am J Nephrol. 2021;52(12):977-978. doi: 10.1159/000520156. Epub 2021 Nov 2.
3
Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.研究用缺氧诱导因子脯氨酰羟化酶抑制剂（HIF-PHI）治疗与慢性肾脏病相关的贫血。
Expert Opin Investig Drugs. 2018 Jul;27(7):613-621. doi: 10.1080/13543784.2018.1493455. Epub 2018 Jul 12.
4
ExActa HIF prolyl hydroxylase inhibitors-The new lifestyle drug?依克那肽脯氨酰羟化酶抑制剂——新型生活方式药物？
Acta Physiol (Oxf). 2019 Nov;227(3):e13370. doi: 10.1111/apha.13370. Epub 2019 Sep 17.
5
Hypoxia signaling in renal pericytes-is it safe to activate?肾周细胞缺氧信号转导——激活它安全吗？
Kidney Int. 2021 Jun;99(6):1267-1269. doi: 10.1016/j.kint.2021.02.014.
6
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD.用于慢性肾脏病贫血的缺氧诱导因子脯氨酰羟化酶抑制剂
N Engl J Med. 2021 Dec 16;385(25):2390-2391. doi: 10.1056/NEJMe2117100. Epub 2021 Nov 5.
7
Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors.体外筛选方法在缺氧诱导因子脯氨酰羟化酶抑制剂中的应用。
Bioorg Med Chem. 2017 Aug 1;25(15):3891-3899. doi: 10.1016/j.bmc.2017.05.026. Epub 2017 May 13.
8
Initial experience of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with heart failure and renal anemia.缺氧诱导因子脯氨酰羟化酶抑制剂用于心力衰竭合并肾性贫血患者的初步经验
Heart Vessels. 2023 Feb;38(2):284-290. doi: 10.1007/s00380-022-02181-1. Epub 2022 Oct 7.
9
Oxygen sensors as therapeutic targets in kidney disease.氧传感器作为肾脏疾病的治疗靶点。
Nephrol Ther. 2017 Apr;13 Suppl 1:S29-S34. doi: 10.1016/j.nephro.2017.01.015.
10
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on iron regulation in non-dialysis-dependent chronic kidney disease patients with anemia: A systematic review and meta-analysis.缺氧诱导因子脯氨酰羟化酶抑制剂对非透析依赖性慢性肾脏病伴贫血患者铁调节的影响：系统评价和荟萃分析。
Pharmacol Res. 2021 Jan;163:105256. doi: 10.1016/j.phrs.2020.105256. Epub 2020 Oct 18.

引用本文的文献

1
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.皮下注射阿法依泊汀与甲氧基聚乙二醇化β-促红细胞生成素治疗3或4期慢性肾脏病患者的非劣效性：一项3期试验的见解
Nephrology (Carlton). 2025 May;30(5):e70046. doi: 10.1111/nep.70046.
2
Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.达普司他在ASCEND-D试验中对腹膜透析患者的疗效和安全性
Nephrol Dial Transplant. 2025 Jun 30;40(7):1332-1341. doi: 10.1093/ndt/gfae273.
3
An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease.
一项关于缺氧诱导因子脯氨酰羟化酶抑制剂治疗非透析依赖性慢性肾脏病贫血的疗效和安全性的更新荟萃分析。
Ren Fail. 2023;45(2):2258986. doi: 10.1080/0886022X.2023.2258986. Epub 2023 Sep 19.
4
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.缺氧诱导因子脯氨酰羟化酶抑制剂的构效关系及转录组分析
Antioxidants (Basel). 2022 Jan 24;11(2):220. doi: 10.3390/antiox11020220.

HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety.

作者信息

Roger Simon D, Coyne Daniel W

机构信息

Department of Renal Medicine, Gosford Hospital, Gosford, New South Wales, Australia.

Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.

出版信息

Am J Nephrol. 2021;52(10-11):894-898. doi: 10.1159/000518073. Epub 2021 Sep 16.

DOI:10.1159/000518073
PMID:34535582
Abstract
摘要